|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019693,
umls-concept:C0020402,
umls-concept:C0034107,
umls-concept:C0035820,
umls-concept:C0087111,
umls-concept:C0205088,
umls-concept:C0205225,
umls-concept:C0205466,
umls-concept:C0206034,
umls-concept:C1274040,
umls-concept:C1512900,
umls-concept:C1999177,
umls-concept:C2587213
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-6-8
|
|
pubmed:abstractText |
Structured treatment interruptions (STIs) have been postulated to improve virologic control in primary HIV infection (PHI) by stimulating HIV-specific T-lymphocyte immunity. The addition of hydroxyurea (HU) may reduce viral production from activated CD4 cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1525-4135
|
|
pubmed:author |
pubmed-author:BlochMark TMT,
pubmed-author:CarrAndrewA,
pubmed-author:CooperDavid ADA,
pubmed-author:FinlaysonRobert JRJ,
pubmed-author:GreyPatP,
pubmed-author:IrvineKathyK,
pubmed-author:KaldorJohn MJM,
pubmed-author:KelleherAnthony DAD,
pubmed-author:LawMatthewM,
pubmed-author:McFarlaneRobertR,
pubmed-author:PetoumenosKathyK,
pubmed-author:QuanDickD,
pubmed-author:SmithDon EDE,
pubmed-author:ZaundersJohn JJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
192-202
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16688094-Adult,
pubmed-meshheading:16688094-Anti-HIV Agents,
pubmed-meshheading:16688094-CD4 Lymphocyte Count,
pubmed-meshheading:16688094-Drug Administration Schedule,
pubmed-meshheading:16688094-Drug Therapy, Combination,
pubmed-meshheading:16688094-HIV,
pubmed-meshheading:16688094-HIV Infections,
pubmed-meshheading:16688094-Homosexuality,
pubmed-meshheading:16688094-Humans,
pubmed-meshheading:16688094-Hydroxyurea,
pubmed-meshheading:16688094-Male,
pubmed-meshheading:16688094-RNA, Viral,
pubmed-meshheading:16688094-Treatment Outcome,
pubmed-meshheading:16688094-Viral Load
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: final results from a randomized clinical trial (Pulse).
|
|
pubmed:affiliation |
Holdsworth House Medical Practice, Sydney, New South Wales, Australia.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
